Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

844 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Current strategies for the inhibition of hepatic glucose production in type 2 diabetes.
Edgerton DS, Johnson KM, Cherrington AD. Edgerton DS, et al. Front Biosci (Landmark Ed). 2009 Jan 1;14:1169-81. doi: 10.2741/3301. Front Biosci (Landmark Ed). 2009. PMID: 19273123 Review.
Endogenously released GLP-1 is not sufficient to alter postprandial glucose regulation in the dog.
Johnson KM, Farmer T, Schurr K, Patrick Donahue E, Farmer B, Neal D, Cherrington AD. Johnson KM, et al. Endocrine. 2011 Jun;39(3):229-34. doi: 10.1007/s12020-011-9441-x. Epub 2011 Mar 10. Endocrine. 2011. PMID: 21547512 Free PMC article.
Effects of intraportal exenatide on hepatic glucose metabolism in the conscious dog.
Edgerton DS, An Z, Johnson KM, Farmer T, Farmer B, Neal D, Cherrington AD. Edgerton DS, et al. Am J Physiol Endocrinol Metab. 2013 Jul 1;305(1):E132-9. doi: 10.1152/ajpendo.00160.2013. Epub 2013 May 14. Am J Physiol Endocrinol Metab. 2013. PMID: 23673158 Free PMC article.
Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo.
Edgerton DS, Ramnanan CJ, Grueter CA, Johnson KM, Lautz M, Neal DW, Williams PE, Cherrington AD. Edgerton DS, et al. Diabetes. 2009 Dec;58(12):2766-75. doi: 10.2337/db09-0328. Epub 2009 Sep 15. Diabetes. 2009. PMID: 19755527 Free PMC article.
Inhibition of dipeptidyl peptidase-4 by vildagliptin during glucagon-like Peptide 1 infusion increases liver glucose uptake in the conscious dog.
Edgerton DS, Johnson KM, Neal DW, Scott M, Hobbs CH, Zhang X, Duttaroy A, Cherrington AD. Edgerton DS, et al. Diabetes. 2009 Jan;58(1):243-9. doi: 10.2337/db08-0515. Epub 2008 Oct 7. Diabetes. 2009. PMID: 18840785 Free PMC article.
Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
Johnson KM, Edgerton DS, Rodewald T, Scott M, Farmer B, Neal D, Cherrington AD. Johnson KM, et al. Am J Physiol Endocrinol Metab. 2007 Oct;293(4):E1085-91. doi: 10.1152/ajpendo.00275.2007. Epub 2007 Aug 7. Am J Physiol Endocrinol Metab. 2007. PMID: 17684104
Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization.
Johnson KM, Edgerton DS, Rodewald T, Scott M, Farmer B, Neal D, Cherrington AD. Johnson KM, et al. Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E380-4. doi: 10.1152/ajpendo.00642.2007. Epub 2007 Dec 4. Am J Physiol Endocrinol Metab. 2008. PMID: 18056788
Utilisation of advanced MRI techniques to understand neurovascular complications of PHACE syndrome: a case of arterial stenosis and dissection.
Eisenmenger LB, Rivera-Rivera LA, Johnson KM, Drolet BA. Eisenmenger LB, et al. Among authors: johnson km. BMJ Case Rep. 2020 Sep 14;13(9):e235992. doi: 10.1136/bcr-2020-235992. BMJ Case Rep. 2020. PMID: 32928832
844 results
Jump to page
Feedback